AP
GILD icon

Atlas Principals’s Gilead Sciences GILD Stock Holding History

Atlas Principals’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-125,500
Closed -$8.11M – 43
2021
Q1 		$8.11M Buy
125,500
+85,500
+214% +$5.51M 2.89% 9
2020
Q4 		$2.33M Buy
+40,000
New +$2.41M 0.97% 28
2020
Q1 		– Sell
-120,000
Closed -$7.8M – 46
2019
Q4 		$7.8M Buy
+120,000
New +$7.81M 2.82% 8

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Atlas Principals's GILD Position: Q2 2021 in Review

Atlas Principals sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 25,000 shares — an estimated $1.62M sold.

Atlas Principals first reported a position in GILD in Q1 2021 and held it in 1 quarter. The position peaked at $1.62M in Q1 2021. 1,545 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • Atlas Principals reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
  • Atlas Principals sold 25,000 Gilead Sciences shares in Q2 2021, an estimated $1.62M.
  • Atlas Principals first reported a position in Gilead Sciences in Q1 2021 and held it in 1 quarter.
  • Atlas Principals's Gilead Sciences position peaked at $1.62M in Q1 2021.
  • 1,545 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on Atlas Principals's 13F filing for Q2 2021, filed 16 Aug 2021.